Themes

Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to im...

This research service aims to profile some of the promising biotech companies in Europe across different countries and segments.

This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe. It includes technology trends, challenges, drivers, restraints, competitive structure, strategic recommendations and list of market participants.

This research service examines the contract research organization market highlighting on what pharmaceutical and biotechnology companies want. The research service highlights services what pharmaceutical and biotech companies want from the contract research organizations (CROs) and the criteria they use in selecting CROs. The countries covered in t...

This research service provides an overview of the pharma-biotech industry in terms of critical success factors and alliance management.

This Research Service gives an extensive coverage of the Australian and New Zealand Biotechnology Industries. The study has be classified based on five key value drivers of the industry namely the Environmental Factors, Research and Development, Branding, Partnerships and Distribution. Every value driver has been disucced at length with statistical...

This is an indepth study benchmarking the taiwan biotechnology industry with the global developing and developed countries.It also features the value chain analysis of key verticals defining the Tawian biotech and related sectors.

This strategic analysis service provides detailed analysis of opportunities for European pharmaceutical and biotechnology companies in India and China. The service is in PowerPoint format.

This strategic analysis service looks into the market entry issues in the 'new' European Union (EU) countries. The service in powerpoint format (approximately 90 slides) focuses not just on the challenges for pharmaceutical and biotechnology companies wishing to enter the 'new' EU countries but also identifies opportunities within the 'new' EU for ...